Clinical Trial Update: Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

View source ↗

Summary

A clinical trial update notes the evaluation of sodium-glucose cotransporter-2 inhibitors for non-alcoholic fatty liver disease, with the study currently not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Fibrosis
• Hepatic Steatosis
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Assiut University | Conditions: Non Alcholic Fatty Liver Disease, Hepatic Steatosis | Status: NOT_YET_RECRUITING